3D High-Resolution Diffusion-Weighted MRI at 3T: Preliminary Application in Prostate Cancer Patients Undergoing Active Surveillance Protocol for Low-Risk Prostate Cancer

被引:15
|
作者
Nguyen, Christopher [1 ,2 ]
Sharif-Afshar, Ali-Reza [3 ]
Fan, Zhaoyang [1 ]
Xie, Yibin [1 ,2 ]
Wilson, Sidney [2 ]
Bi, Xiaoming [4 ]
Payor, Lucas [5 ]
Saouaf, Rola [5 ]
Kim, Hyung [3 ]
Li, Debiao [1 ,2 ]
机构
[1] Cedars Sinai Med Ctr, Biomed Imaging Res Inst, Pacific Theatres PACT Suite 800,8700 Beverly Blvd, Los Angeles, CA 90048 USA
[2] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA
[3] Cedars Sinai Med Ctr, Div Urol, Dept Surg, Los Angeles, CA 90048 USA
[4] Siemens Healthcare, Los Angeles, CA USA
[5] Cedars Sinai Med Ctr, Dept Radiol, Los Angeles, CA 90048 USA
关键词
diffusion preparation; bSSFP; diffusion-weighted; prostate cancer; MRI; SPIN-ECHO; COEFFICIENT; BRAIN;
D O I
10.1002/mrm.25609
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To improve spatial resolution and image quality of diffusion-weighted (DW) MRI in detecting low-risk prostate cancer (lrPC) in patients undergoing active surveillance protocol (AS-PC), we propose the application of a diffusion-prepared balanced steady-state free precession (bSSFP) technique capable of multishot acquisition. Methods: Diffusion-prepared bSSFP was compared with single-shot DW echo planar imaging (SS-DW-EPI) at two prescribed resolutions (2.1 x 2.1 x 3.5mm(3), 0.9 x 0.9 x 3.5 mm 3) in nine healthy subjects and nine AS-PC patients. Geometric distortion and susceptibility artifacts were quantitatively assessed in all subjects. In AS-PC patients, lesion detection via blinded multiparametric MRI including T1-weighted, T2-weighted, dynamic contrast-enhanced imaging, and along with either of two DW methods were evaluated against 12-point biopsy. Results: Geometric distortion and susceptibility artifacts were significantly less for diffusion-prepared bSSFP at both prescribed spatial resolutions than SS-DW-EPI. Apparent diffusion coefficients of healthy prostate tissue were concordant between the two DW methods at both spatial resolutions. In AS-PC patients, multiparametric MRI with diffusion-prepared bSSFP had greater sensitivity (94%, 63%), accuracy (76%, 67%), positive-predictive value (54%, 48%), negative-predictive value (97%, 82%), and area under the curve (0.80, 0.67) than with SS-DW-EPI. Conclusions: The proposed diffusion-prepared technique with higher spatial resolution and improved image quality over SS-DW-EPI resulted in better multiparametric MRI detection of lrPC in AS-PC patients. (C) 2015 Wiley Periodicals,
引用
收藏
页码:616 / 626
页数:11
相关论文
共 50 条
  • [11] Detectability of low and intermediate or high risk prostate cancer with combined T2-weighted and diffusion-weighted MRI
    Kyung Won Doo
    Deuk Jae Sung
    Beom Jin Park
    Min Ju Kim
    Sung Bum Cho
    Yu Whan Oh
    Young Hwii Ko
    Kyung Sook Yang
    European Radiology, 2012, 22 : 1812 - 1819
  • [12] Detectability of low and intermediate or high risk prostate cancer with combined T2-weighted and diffusion-weighted MRI
    Doo, Kyung Won
    Sung, Deuk Jae
    Park, Beom Jin
    Kim, Min Ju
    Cho, Sung Bum
    Oh, Yu Whan
    Ko, Young Hwii
    Yang, Kyung Sook
    EUROPEAN RADIOLOGY, 2012, 22 (08) : 1812 - 1819
  • [13] Assessment of Response to Radiotherapy for Prostate Cancer: Value of Diffusion-Weighted MRI at 3 T
    Song, Inyoung
    Kim, Chan Kyo
    Park, Byung Kwan
    Park, Won
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2010, 194 (06) : W477 - W482
  • [14] Prospective Pilot Trial to Evaluate a High Resolution Diffusion-Weighted MRI in Prostate Cancer Patients
    Sharif-Afshar, Ali-Reza
    Christopher Nguyen
    Feng, Tom S.
    Payor, Lucas
    Fan, Zhaoyang
    Saouaf, Rola
    Li, Debiao
    Kim, Hyung L.
    EBIOMEDICINE, 2016, 7 : 80 - 84
  • [15] Prediction of Locally Recurrent Prostate Cancer after Radiation Therapy: Incremental Value of 3T Diffusion-Weighted MRI
    Kim, Chan Kyo
    Park, Byung Kwan
    Lee, Hyun Moo
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2009, 29 (02) : 391 - 397
  • [16] Enzalutamide versus active Surveillance in Patients with Low-risk Prostate Cancer
    Dunst, Juergen
    Krug, David
    STRAHLENTHERAPIE UND ONKOLOGIE, 2023, 199 (02) : 201 - 203
  • [17] Low-Risk Prostate Cancer Patients on Active Surveillance: Utility of Immunohistochemistry
    Poveda, J.
    Eldefrawy, A.
    Umar, S.
    Soloway, M.
    Jorda, M.
    MODERN PATHOLOGY, 2013, 26 : 241A - 241A
  • [18] Low-Risk Prostate Cancer Patients on Active Surveillance: Utility of Immunohistochemistry
    Poveda, J.
    Eldefrawy, A.
    Umar, S.
    Soloway, M.
    Jorda, M.
    LABORATORY INVESTIGATION, 2013, 93 : 241A - 241A
  • [19] A Decision Analysis Comparing 3 Active Surveillance Protocols for the Treatment of Patients With Low-Risk Prostate Cancer
    White, Craig
    Nimeh, Tony
    Gazelle, G. Scott
    Weinstein, Milton C.
    Loughlin, Kevin R.
    CANCER, 2019, 125 (06) : 952 - 962
  • [20] An assessment of Prostate Cancer Research International: Active Surveillance (PRIAS) criteria for active surveillance of clinically low-risk prostate cancer patients
    da Silva, Vitor
    Cagiannos, Ilias
    Lavallee, Luke T.
    Mallick, Ranjeeta
    Witiuk, Kelsey
    Cnossen, Sonya
    Eastham, James A.
    Fergusson, Dean A.
    Morash, Chris
    Breau, Rodney H.
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2017, 11 (08): : 238 - 243